Indica Labs is pleased to announce our London HALO® User Group Meeting at Hilton London Metropole on December 10 from 12:00 – 16:00. A lunch will be provided to all pre-registered attendees and a drinks reception will follow the event from 16:00 – 17:00.
Our program this year features three distinguished guest speakers who will discuss how they use AI-based phenotypers in HALO AI to advance breast cancer research, how HALO AP® is being deployed at Med Uni Graz for primary diagnostics, and how Breast IHC AI is advancing diagnostics at the University Hospital Bern. In addition to our guest speakers, Indica Labs will present an introduction and live demonstration of our image analysis and image management platforms for life sciences, introduce our offering in clinical AI and Cloud Services, and reflect on milestones and innovations enabled by HALO AP®.
We welcome anyone who is interested in learning more about Indica Labs’ quantitative digital pathology solutions to register for the meeting. You do not need to be a current Indica Labs customer to attend.
Owkin’s MSIntuit® CRC v2*, a next-generation AI diagnostic aimed at transforming the detection and treatment of colorectal cancer, will be integrated into Proscia’s Concentriq® software platform, making it available as part of...